• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾血管性高血压和缺血性肾病的发病机制与管理

Pathogenesis and management of renovascular hypertension and ischemic nephropathy.

作者信息

Yerram P, Karuparthi P R, Chaudhary K

机构信息

Department of Internal Medicine, University of Missouri, Columbia, MO, USA.

出版信息

Minerva Urol Nefrol. 2012 Mar;64(1):63-72.

PMID:22402318
Abstract

Renovascular disease is an important cause of secondary hypertension and renal impairment. Atherosclerotic renal artery stenosis (ARAS) is the most important cause of renal artery stenosis (RAS), and has been linked to increased cardiovascular risk. The pathogenesis of renovascular hypertension is complex, but is mainly due to the over-activation of Renin-Angiotensin-Aldosterone system. A major consequence of untreated RAS is ischemic nephropathy, which is due to the sustained reduction in renal perfusion leading to derangement of microvascular function, and eventual development of interstitial fibrosis. Diagnosis of these conditions can be complex, sometimes needing invasive testing. Aggressive medical management is key to preventing progression of disease, as the role of revascularization in the management of ARAS is still not well defined.

摘要

肾血管疾病是继发性高血压和肾功能损害的重要原因。动脉粥样硬化性肾动脉狭窄(ARAS)是肾动脉狭窄(RAS)的最重要原因,并与心血管风险增加有关。肾血管性高血压的发病机制复杂,但主要是由于肾素-血管紧张素-醛固酮系统过度激活。未经治疗的RAS的一个主要后果是缺血性肾病,这是由于肾灌注持续减少导致微血管功能紊乱,最终发展为间质纤维化。这些疾病的诊断可能很复杂,有时需要进行侵入性检查。积极的药物治疗是预防疾病进展的关键,因为血管重建在ARAS治疗中的作用仍未明确。

相似文献

1
Pathogenesis and management of renovascular hypertension and ischemic nephropathy.肾血管性高血压和缺血性肾病的发病机制与管理
Minerva Urol Nefrol. 2012 Mar;64(1):63-72.
2
The role of the renin-angiotensin-aldosterone system in renal artery stenosis, renovascular hypertension, and ischemic nephropathy: diagnostic implications.肾素-血管紧张素-醛固酮系统在肾动脉狭窄、肾血管性高血压和缺血性肾病中的作用:诊断意义。
Prog Cardiovasc Dis. 2009 Nov-Dec;52(3):204-8. doi: 10.1016/j.pcad.2009.09.005.
3
Renal artery stenosis.肾动脉狭窄
Cardiol Clin. 2015 Feb;33(1):59-73. doi: 10.1016/j.ccl.2014.09.006.
4
Evidence-based medicine in renal artery stenting.肾动脉支架置入术中的循证医学
J Cardiovasc Surg (Torino). 2010 Oct;51(5):755-63.
5
Renovascular Hypertension: Novel Insights.肾血管性高血压:新见解
Curr Hypertens Rev. 2020;16(1):24-29. doi: 10.2174/1573402115666190416153321.
6
Epidemiology and optimal management in patients with renal artery stenosis.肾动脉狭窄患者的流行病学和最佳管理。
J Nephrol. 2012 Nov-Dec;25(6):872-8. doi: 10.5301/jn.5000206.
7
Renovascular Hypertension.肾血管性高血压。
Endocrinol Metab Clin North Am. 2019 Dec;48(4):765-778. doi: 10.1016/j.ecl.2019.08.007. Epub 2019 Sep 19.
8
How to manage hypertension with atherosclerotic renal artery stenosis?如何治疗伴有动脉粥样硬化性肾动脉狭窄的高血压?
J Cardiovasc Surg (Torino). 2017 Apr;58(2):329-338. doi: 10.23736/S0021-9509.16.09827-X. Epub 2016 Dec 19.
9
Ischemic nephropathy: more than a simple renal artery narrowing.缺血性肾病:不止是单纯的肾动脉狭窄。
Iran J Kidney Dis. 2013 Mar;7(2):82-100.
10
New Insights Into Pathophysiology, Diagnosis, and Treatment of Renovascular Hypertension.肾血管性高血压病理生理学、诊断及治疗的新见解
Iran J Kidney Dis. 2017 Mar;11(2):79-89.

引用本文的文献

1
Renovascular hypertension treated by renal artery embolization.经肾动脉栓塞治疗的肾血管性高血压。
Yonsei Med J. 2014 Jan;55(1):273-5. doi: 10.3349/ymj.2014.55.1.273.
2
Mesenchymal stem cells (MSC) prevented the progression of renovascular hypertension, improved renal function and architecture.间充质干细胞 (MSC) 可阻止肾血管性高血压的进展,改善肾功能和肾脏结构。
PLoS One. 2013 Nov 4;8(11):e78464. doi: 10.1371/journal.pone.0078464. eCollection 2013.